|Application:||Gene expression microarray analysis|
|Number of samples:||60|
|Release date:||Dec 1 2014|
|Last update date:||Aug 16 2018|
|Diseases:||Breast Neoplasms, Neoplasms, Tumor Lysis Syndrome|
|Dataset link||Molecular diversity of breast cancers at the time of endocrine resistance [mRNA]|
Total RNA extracted from 60 fresh-frozen clinical biopsies of breast cancer at the time of endocrine resistance has been profiled with Illumina HT-12 whole-genome expression micro-arrays. The profiles have been analysied using un-supervised and pathway-focused bioinformatics techniques to study diversity between tumours and potential mechanisms of resistance for individual tumours.